In trials, overall GI events rose with higher doses and faster escalations
They are crucial for enzyme function, tissue structure, delivery of nutrients, and cellular processes
Fellow pharma powerhouse Roche has also jumped into the oral obesity arena with the $2.7 billion acquisition of Carmot Therapeutics in December 2023, giving it access to CT-388 and CT-868, both of which are dual agonists of the GLP-1 and GIP receptors with best-in-class potential for obesity, Roche said at the time
Months 2-3: Accelerating loss as doses increase
Brand-name list prices run roughly $1,000 to $1,350 per month for both Wegovy and Zepbound, though Eli Lilly's LillyDirect direct-pay vials for Zepbound have brought entry doses closer to $349 to $499 per month
What Is the Best Absorbed Form of L-Carnitine